Calliditas Therapeutics

-$0.52 (-2.78%) As of 5:28 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CALT and other ETFs, options, and stocks.

About CALT

Calliditas Therapeutics AB clinical-stage biopharmaceutical company. It engages in the identification, development, and commercialization of novel treatments in orphan indications.

CEO
Renée Julie Elisabet Aguiar-Lucander
Employees
66
Headquarters
Stockholm, Stockholm
Founded
2004

CALT Key Statistics

Market cap
471.47M
Price-Earnings ratio
—
Dividend yield
—
Average volume
18.34K
High today
$19.00
Low today
$17.98
Open price
$18.40
Volume
6.97K
52 Week high
$33.19
52 Week low
$12.55

CALT Earnings

-$1.02
-$0.66
-$0.31
$0.05
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$1.02 per share
Actual
-$0.85 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure